Extracorporeal fluid removal in heart failure patients

Fluid Overload

Volumn , Issue , 2010, Pages 173-198

  Costanzo, Maria Rosa ^a   Agostoni, Piergiuseppe ^b   Marenzi, Giancarlo ^b  

^a Midwest Heart Foundation   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; HEART FAILURE; HEMOFILTRATION; HUMAN; METABOLIC DISORDER; REVIEW;

HEART FAILURE; HEMOFILTRATION; HUMANS; RENAL INSUFFICIENCY, CHRONIC; WATER-ELECTROLYTE IMBALANCE;

EID: 77955495201     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783805594172.ch16     Document Type: Chapter

References (104)

1. Thom T, Haase N, Rosamond W, et al: Heart Disease and Stroke Statistics -2006 Update. A report from the American Heart Association Statistics Committee and the Stroke Statistics Subcommittee. Circulation 2006;113:e85-e151.
2. Adams KF, Fonarow GC, Emerman CL, et al: Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209 -216.
3. Jain P, Massie BM, Gattis WA, et al: Current medical treatment for exacerbation of chronic heart failure resulting in hospitaliza-tion. Am Heart J 2003;145:S3-S17.
4. Drazner MH, Rame JE, Stevenson LW, Dries DL: Prognostic importance of elevated jugu-lar venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574-581.
5. Androne AS, Katz SD, Lund L, et al: Hemodilution is common in patients with advanced heart failure. Circulation 2003;107: 226-229.
6. Jessup M, Abraham WT, Casey DE, et al: 2009 Focused Update: ACCF/ AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.
7. Schrier RW: Role of diminished renal func-tion in cardiovascular mortality. Marker or pathogenetic factor? J Am Coll Cardiol 2006; 47:1-8.
8. Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 2001; 96:132-143.
9. Francis GS, Benedict C, Johnstone DE, et al: Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82: 1724-1729.
10. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E: Diuretic use, progres-sive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003;42:705-708.
11. Sharma A, Hermann DD, Mehta RL: Clinical benefit and approach of ultrafiltration in acute heart failure. Cardiology 2001;96:144-154.
12. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P: Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001;38:963-968.
13. Rimondini A, Cipolla C, Della Bella P, et al: Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med 1987;83:43-48.
14. Jaski BE, Ha J, Denys BG, Lamba S, Trupp RJ, Abraham WT: Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003;9:227-231.
15. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D: Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-3072.
16. Tsuyuki RT, Shibata MG, Nillson C, Hervas-Malo M: Contemporary burden of illness of congestive heart failure in Canada. Can Cardiol 2003;19:436-438.
17. Cleland JGF, Swedberg K, Follath F, et al, for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology: The EuroHeart Failure survey programme -a survey on the quality of care among patients with heart failure in Europe. 1. Patient char-acteristics and diagnosis. Eur. Heart J 2003; 24:442-463.
18. Jong P, Vowinkel E, Liu PP, et al: Prognosis and determinants of survival in patients newly hospitalized for heart failure. A population-based study. Arch Intern Med 2002;162:1689-1694.
19. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW: Temporal trends in clinical characteristics, treat-ments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-1028.
20. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J: High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007;13:422-430.
21. Fonarow GC, Stough WG, Abraham WT, et al: Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768-777.
22. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC: Clinical pre-sentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 2006;47:76-84.
23. Sweitzer NK, Lopatin M, Yancy CW, Mills RM, Stevenson LW: Comparison of clinical features and outcomes of patients hospital-ized with heart failure and normal ejection fraction (> or = 55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions. Am J Cardiol 2008;101:1151-1156.
24. Gheorghiade M, Filippatos G, De Luca L, Burnett J: Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 2006;119:S3-S10.
25. Adamson PB, Magalski A, Braunschweig F, et al: Ongoing right ventricular hemo-dynamics in heart failure: clinical value of measurements derived from an implant-able monitoring system. J Am Coll Cardiol 2003;41:565-571.
26. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM: Patterns of weight change preceding hospitalization for heart failure. Circulation 2007;116:1549-1554.
27. Ahmed A, Allman RM, Fonarow GC, et al: Incident heart failure hospitalization and subsequent mortality in chronic heart fail-ure: a propensity-matched study. J Card Fail 2008;14:211-218.
28. Solomon SD, Dobson J, Pocock S, et al: Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007;116:1482-1487.
29. Fonarow GC, Abraham WT, Albert NM, et al: Factors identified as precipitating hospital admissions for heart failure and clinical out-comes: findings from OPTIMIZE-HF. Arch Intern Med 2008;168:847-854.
30. Nieminen MS, Brutsaert D, Dickstein K, et al: EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-2736.
31. Gheorghiade M, Filippatos G: Reassessing treatment of acute heart failure syn-dromes: the ADHERE registry. Eur Heart J 2005;7(suppl):B13-B19.
32. Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M: Predischarge initiation of carvedilol in patients hospital-ized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 2004;43:1534-1541.
33. Gheorghiade M, Abraham WT, Albert NM, et al: Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-988.
34. Wang NC, Maggioni AP, Konstam MA, et al: Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 2008;299:2656-2656.
35. Gheorghiade M, Abraham WT, Albert NM, et al: Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006;296:2217-2226.
36. Ahmed A, Rich MW, Fleg JL, et al: Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digi-talis investigation group trial. Circulation 2006;114:397-403.
37. Shah SJ, Gheorghiade M: Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 2008;300:431-433.
38. Gheorghiade M, Gattis WA, O'Connor CM, et al: Effects of tolvaptan, a vasopres-sin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 2004;291:1963-1971.
39. Steimle AE, Stevenson LW, Chelimski-Fallick C: Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 1997;96:1165-1172.
40. Mullens W, Abrahams Z, Francis GS, et al: Importance of Venous Congestion for worsening of renal function in advanced dec-ompensated heart failure. J Am Coll Cardiol 2009;53:589-596.
41. Verbalis JG: Disorders of body water homeo-stasis. Best Pract Res Clin Endocrinol Metab 2003;17:471-503.
42. Schrier RW: Body fluid regulation in health and disease: a unifying hypothesis. Ann Intern Med 1990;113:155-159.
43. Castrop H, Schweda F, Mizel D, et al: Permissive role of nitric oxide in macula densa control of renin secretion. Am J Physiol Renal Physiol 2004;286:F848-F857.
44. Xu DL, Martin PY, Ohara M, et al: Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest 1997;99:1500-1505.
45. Winton FR: The Influence of venous pressure on the isolated mammalian kidney. J Physiol 1931;72:49-61.
46. Firth JD, Raine AE, Ledingham JG: Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1988;i:1033-1035.
47. Nohria A, Hasselblad V, Stebbins A, et al: Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 2008;51:1268-1274.
48. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
49. Schrier RW: Blood urea nitrogen and serum creatinine. Not married in heart failure. Circ Heart Fail 2008;1:2-5.
50. Klein L, Massie BM, Leimberger JD, et al: Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbation of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail 2008;1:25-33.
51. Ellison DH: Diuretic resistance: physiol-ogy and therapeutics. Semin Nephrol 1999;19:581-597.
52. Rubboli A. Sobotka PA, Euler DE: Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am J Physiol Heart Circ Physiol 1994;267:H1054-H1061.
53. Peacock WF, De Marco T, Fonarow GC, et al: Cardiac troponin and outcome in acute heart failure N Engl J Med 2008;358:2117-2126.
54. Ronco C, House AA, Haapio M: Cardiorenal syndrome: refining the definition of a com-plex symbiosis gone wrong. Intensive Care Med 2008;34:957-962.
55. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2005;26:11-17.
56. Damman K, van Deursen VM, Navis G, et al: Increased central venous pressure is associ-ated with impaired renal function and mor-tality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-588.
57. Peacock WF, Costanzo MR, De Marco T, et al: Impact of intravenous diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 2008;113:12-19.
58. Eshaghian S, Horwich TB, Fonarow GC: Relation of loop diuretic dose to mortal-ity in advanced heart failure. Am J Cardiol 2006;9712:1759-1764.
59. Kolff WJ, Leonards JR: Reduction of other-wise intractable edema by dialysis or filtra-tion. Cleve Clin Q 1954;212:61-71.
60. Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP: Continuous arte-riovenous hemofiltration in the critically ill patient. Clinical use and operational charac-teristics. Ann Intern Med 1983;994:455-460.
61. Marenzi G, Grazi S, Giraldi F, Lauri G, Perego G, Guazzi M, Salvioni A, Guazzi MD: Interrelation of humoral factors, hemodynamics, and fluid and salt metabo-lism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 1993;941:49-56.
62. Pepi M, Marenzi GC, Agostoni PG, Doria E, Barbier P, Muratori M, Celeste F, Guazzi MD: Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates. Br Heart J 1993;702:135-140.
63. Agostoni PG, Marenzi GC, Pepi M, Doria E, Salvioni A, Perego G, Lauri G, Giraldi F, Grazi S, Guazzi MD: Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993;212:424-431.
64. Agostoni PG, Marenzi GC, Sganzerla P, Assanelli E, Guazzi M, Perego GB, Lauri G, Doria E, Pepi M, Guazzi MD: Lung-heart interaction as a substrate for the improve-ment in exercise capacity after body fluid volume depletion in moderate congestive heart failure. Am J Cardiol 1995;7611:793-798.
65. Cipolla CM, Grazi S, Rimondini A, Susini G, Guazzi M, Della Bella P, Guazzi MD: Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. Am J Cardiol 1990;6612:987-994.
66. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P: Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005;4611:2047-2051.
67. Agostoni P, Marenzi G, Lauri G, Perego G, Schianni M, Sganzerla P, Guazzi MD: Sustained improvement in functional capac-ity after removal of body fluid with isolated ultrafiltration in chronic cardiac insuffi-ciency: failure of furosemide to provide the same result. Am J Med 1994;963:191-199.
68. Coraim FI, Wolner E: Continuous hemo-filtration for the failing heart. New Horiz 1995;3:725-731.
69. Canaud B, Leblanc M, Leray-Moragues H, et al: Slow continuous ultrafiltration for refrac-tory congestive heart failure. Nephrol Dial Transplant 1998;13(suppl 4):51-55.
70. Bellomo R, Ronco C: Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int 1998;66(suppl):S106-S109.
71. Schetz MRC: Classical and alternative indica-tions for continuous renal replacement ther-apy. Kidney Int 1998;66(suppl):S129-S132.
72. Manns M, Siglar MH, Teehan BP: Continuous renal replacement therapies: an update. Am J Kidney Dis 1998;32:185-207.
73. Ellison DH, Velazquez H, Wright FS: Adaptation of the distal convoluted tubule of the rat: structural and functional effects of dietary salt intake and chronic diuretic infu-sion. J Clin Invest1989;83:113-126.
74. Ronco C, Bellomo R: Continuous renal replacement therapy: evolution in technol-ogy and current nomenclature. Kidney Int 1998:66(suppl):S160-S164.
75. Bellomo R, Farmer M Parkin G, et al: Severe acute renal failure: a comparison of acute continuous hemodiafiltration and conven-tional dialytic therapy. Nephron 1995;71:59-64.
76. Ronco C: Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. 2. Clinical indications and prescription. Nephrol Dial Transplant 1994;9(suppl 4):201-209.
77. Bellomo R, Metha RL: Acute renal replacement in the intensive care unit: now and tomorrow. New Horiz 1995;3:761-767.
78. Bellomo R, Ronco C: Continuous versus intermittent renal replacement therapy in the intensive care unit. Kidney Int 1998;66(suppl):S125-S128.
79. Schetz M: Non-renal indications for continu-ous renal replacement therapy. Kidney Int 1999;72(suppl):S88-S94.
80. Meyer MM: Renal replacement therapies. Crit Care Clin 2000;16:29-58.
81. Bellomo R, Ronco C: Renal dysfunction in patients with cardiac disease and after car-diac surgery. New Horiz 1999;7:524-532.
82. Bellomo R, Raman J, Ronco C: Intensive care unit management of critically ill patients with fluid overload after open heart surgery. Cardiology 2001;96:169-176.
83. Boyle EM, Prohlman TH, Johnson MC, et al: Endothelial cell injury in cardiovas-cular surgery: the systemic inflammatory response. Ann Thorac Surg 1997;63:277-284.
84. Journois D, Pouard P, Greeley WJ, et al: Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines and complement components. Anesthesiology 1994;81:1181-1189.
85. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-526.
86. Bellomo R, McGrath B, Boyce N: Effect of continuous veno-venous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure. Crit Care Med 1994;22:833-837.
87. Bouduin SV, Wiggins, Keogh BF, et al: Continuous veno-venous hemofiltration fol-lowing cardio-pulmonary bypass. Indications and outcome in 35 patients. Intensive Care Med 1993;19:290-293.
88. Levy B, Clavey M, Burtin P, et al: Continuous veno-venous hemofiltration after cardiac surgery. A retrospective study in 16 patients with multiple organ failure. Ann Fr Anesth Reanim 1992;11:436-441.
89. Tsang GMK, Dar M, Clayton D, et al: Hemofiltration in a cardiac intensive care unit: time for a rational approach. ASAIO J 1996;42:M710-M713.
90. Bent P, Tan HK, Bellomo R, et al: Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann Thorac Surg 2001;71:832-837.
91. Asaba H, Bergstrom J, Furst P, et al: Treatment of diuretic resistant fluid reten-tion with ultrafiltration. Acta Med Scand 1978;204:145-149.
92. Gerhardt RE, Abdulla AM, Mach SJ, et al: Isolated ultrafiltration in the treatment of fluid overload in cardiogenic shock. Arch Intern Med 1979;139:358-359.
93. Bart BA, Boyle A, Bank AJ, et al: Randomized controlled trial of ultrafiltration versus usual care for hospitalized patients with heart failure: relief for acutely fluid overloaded patients with decompensated congestive heart failure. J Am Coll Cardiol 2005;46:2043-2046.
94. Costanzo MR, Guglin ME, Saltzberg MT, et al: Ultrafiltration versus intravenous diuret-ics for patients hospitalized for acute dec-ompensated heart failure. J Am Coll Cardiol 2007;49:675-683.
95. Costanzo MR, Saltzberg MT, Jessup M, et al: Ultrafiltration is associated with fewer re-hospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Cardiac Fail, in press.
96. Ali SS, Olinger CC, Sobotka PA, et al: Loop diuretics can cause clinical natriuretic fail-ure: a prescription for volume expansion. Congest Heart Fail 2009;15:1-4.
97. Konstam MA, Gheorghiade M, Burnett JC, et al, for the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Investigators: Effects of oral tolvaptan in patients hospitalized for worsening heart failure. The EVEREST outcome trial. JAMA 2007;297:1319-1331.
98. Abdallah JG, Schreier RW, Edelstein C, et al: Loop diuretic infusion increases thiazide-sensitive Na+/Cl--cotransporter abundance: role of aldosterone J Am Soc Nephrol 2001;12:1335-1341.
99. Domanski M, Tian X, Haigney M, Pitt B: Diuretic use, progressive heart failure, and death in patients in the DIG study. J Cardiac Fail 2006;12:327-332.
100. Kramer B, Schweda F, Riegger G: Diuretic treatment and diuretic resistance in heart failure. Am J Med 1999;106:90-96.
101. He XR, Greenberg S, Briggs J, Schnermann J: Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated secretion. Hypertension 1995; 26:137-142.
102. Nielsen S, Knepper M, Kwon T, et al: Regulation of water balance; in Schrier RW (ed): Diseases of the Kidney and Urinary Tract, ed 7. New York, Lippincott Williams and Wilkins, 2001, pp 109-134.
103. Fang J, Mensah GA, Croft JB, Keenan NL: Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 2008; 52:428-434.
104. Cadnapaphornchai M, Gurevich A, Weinberger H, et al: Pathophysiology of sodium and water retention in heart failure. Cardiology 2001;96:122-131.